United States · FDA National Drug Code directory

Fenofibric Acid

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0115-1325_a1c48695-091f-4924-acf4-a420be16939d
Product NDC
0115-1325
Form
CAPSULE, DELAYED RELEASE
Composition / generic term
FENOFIBRIC ACID
Labeler
Amneal Pharmaceuticals of New York LLC
Marketing category
ANDA
Marketing start / end (source format)
20240601
Source listing expiry
20261231

Source-listed ingredients

  • FENOFIBRIC ACID — 135 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0115-1325-10) · 0115-1325-10

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Fenofibric Acid — United States | Molindra Medicines